SOURCE: Equity News Circuit

Equity News Circuit

May 09, 2013 08:15 ET

Free Research Reports on CYTR, ICUI, MYGN and WBMD Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwired - May 9, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

CytRx Corporation (NASDAQ: CYTR) shares declined 7.84 percent on over three times the average daily volume Wednesday to close at $2.35 a share. The company announced an independent Data Safety Monitoring Committee recommended them to discontinue the Phase 2b clinical trial of tamibarotene for the treatment of advanced non-small-cell lung cancer.

Find out more about CytRx including full access to the free equity report at: www.BedfordReport.com/CYTR

ICU Medical, Inc. (NASDAQ: ICUI) shares spiked 12.65 percent on volume of over 1.0 million shares traded Wednesday to close at $68.83 a share. Bloomberg has reported, citing people familiar with the matter, the company has hired JPMorgan Chase to help explore a sale that could bring over $1 billion.

Find out more about ICU Medical including full access to the free equity report at: www.BedfordReport.com/ICUI

Myriad Genetics, Inc. (NASDAQ: MYGN) shares gained 8.23 percent on volume of 2.69 million shares traded to close at $30.63 a share. The company reported a net income of $37.9 million for the fiscal third quarter, an increase of 28 percent from the net income of $29.6 million in the year ago quarter.

Find out more about Myriad Genetics including full access to the free equity report at: www.BedfordReport.com/MYGN

WebMD Health Corp. (NASDAQ: WBMD) shares surged 9.53 percent on volume of over 3.2 million shares traded Wednesday to close at $27.94 a share. The company reported net loss fell to $1.5 million, or $0.03 per diluted share, for the first quarter of 2013, from a net loss of $7.8 million, or $0.14 diluted share, a year ago.

Find out more about WebMD Health including full access to the free equity report at: www.BedfordReport.com/WBMD

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information